Latest Ratings for VYGR Date Firm Action From To Nov 2021 Chardan Capital Maintains Neutral Oct 2021 Baird Upgrades Neutral Outperform Jun 2021 Compass Point Initiates Coverage On Buy View More Analyst Ratings for VYGR View the Latest Analyst Ratings read more
BMO Capital Markets initiates coverage on Dyne Therapeutics with an Outperform rating, an $84 target, and a projected $4.3 billion peak sales for DYNE-101. Latest Ratings for DYN Date Firm Action From To Oct 2020 JP Morgan Initiates Coverage On Overweight Oct 2020 Stifel Initiates Coverage On Buy Oct 2020 Jefferies Initiates Coverage On Buy…
RBRK stock upgraded by Rosenblatt analyst with PT of $77. Q4 expected to have 33% total revenue growth & 40% subscription revenue growth. RBRK stock up 6.41%. read more
Micron stock is trading higher on Wednesday amid a rebound in technology stocks following softer-than-expected CPI data for February. read more
Alphabet Inc.’s Class C stock (NASDAQ: GOOG) is moving higher Wednesday as Google DeepMind unveils Gemini Robotics, a new AI-driven robotics platform powered by its Gemini 2.0 model. read more
